39 related articles for article (PubMed ID: 9776264)
1. Myocardial perfusion scintigraphy.
Prvulovich E
Clin Med (Lond); 2006; 6(3):263-6. PubMed ID: 16826859
[No Abstract] [Full Text] [Related]
2. The risk of adverse events associated with atropine administration during dobutamine stress echocardiography in cardiac transplant patients: a 28-year single-center experience.
Wang Ji J; Ye S; Haythe J; Schulze PC; Shimbo D
J Card Fail; 2013 Nov; 19(11):762-7. PubMed ID: 24263121
[TBL] [Abstract][Full Text] [Related]
3. Medication and ECG Patterns That May Hinder SPECT Myocardial Perfusion Scans.
Sidrak MMA; De Feo MS; Gorica J; Corica F; Conte M; Filippi L; De Vincentis G; Frantellizzi V
Pharmaceuticals (Basel); 2023 Jun; 16(6):. PubMed ID: 37375801
[TBL] [Abstract][Full Text] [Related]
4. Safety of stress testing in patients with elevated cardiac biomarkers: Are all modalities created equal?
Doukky R; Golzar Y
J Nucl Cardiol; 2017 Apr; 24(2):735-737. PubMed ID: 26888370
[No Abstract] [Full Text] [Related]
5. Serious and potentially life threatening complications of cardiac stress testing: Physiological mechanisms and management strategies.
Dilsizian V; Gewirtz H; Paivanas N; Kitsiou AN; Hage FG; Crone NE; Schwartz RG
J Nucl Cardiol; 2015 Dec; 22(6):1198-213; quiz 1195-7. PubMed ID: 25975944
[No Abstract] [Full Text] [Related]
6. Safety and feasibility of atropine added in patients with sub-maximal heart rate during exercise myocardial perfusion SPECT.
Sarullo FM; Ventimiglia C; Taormina A; Azzarello V; Felice F; Martino A; Paterna S; Di Pasquale P
Int J Cardiovasc Imaging; 2007 Aug; 23(4):511-8. PubMed ID: 17109201
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of stress Tc-99m tetrofosmin SPECT in patients with previous myocardial infarction: impact of scintigraphic extent of coronary artery disease.
Elhendy A; Schinkel AF; van Domburg RT; Bax JJ; Valkema R; Poldermans D
J Nucl Cardiol; 2004; 11(6):704-9. PubMed ID: 15592194
[TBL] [Abstract][Full Text] [Related]
8. Incidence and predictors of heart failure during long-term follow-up after stress Tc-99m sestamibi tomography in patients with suspected coronary artery disease.
Elhendy A; Schinkel AF; van Domburg RT; Bax JJ; Poldermans D
J Nucl Cardiol; 2004; 11(5):527-33. PubMed ID: 15472637
[TBL] [Abstract][Full Text] [Related]
9. Risk stratification of patients after myocardial revascularization by stress Tc-99m tetrofosmin myocardial perfusion tomography.
Elhendy A; Schinkel AF; van Domburg RT; Bax JJ; Valkema R; Poldermans D
J Nucl Cardiol; 2003; 10(6):615-22. PubMed ID: 14668773
[TBL] [Abstract][Full Text] [Related]
10. Use of atropine in patients with submaximal heart rate during exercise myocardial perfusion SPECT.
De Lorenzo A; Foerster J; Sciammarella MG; Suey C; Hayes SW; Friedman JD; Berman DS
J Nucl Cardiol; 2003; 10(1):51-5. PubMed ID: 12569331
[TBL] [Abstract][Full Text] [Related]
11. Pharmacologic radionuclide myocardial perfusion imaging.
Navare SM; Kapetanopoulos A; Heller GV
Curr Cardiol Rep; 2003 Jan; 5(1):16-24. PubMed ID: 12493156
[TBL] [Abstract][Full Text] [Related]
12. Safety and feasibility of atropine added to submaximal exercise stress testing with Tl-201 SPECT for the diagnosis of myocardial ischemia.
Prasad SK; Pennell DJ
J Nucl Cardiol; 2002; 9(6):668-71. PubMed ID: 12466792
[No Abstract] [Full Text] [Related]
13. Safety of dobutamine-atropine stress myocardial perfusion scintigraphy.
Elhendy A; Valkema R; van Domburg RT; Bax JJ; Nierop PR; Cornel JH; Geleijnse ML; Reijs AE; Krenning EP; Roelandt JR
J Nucl Med; 1998 Oct; 39(10):1662-6. PubMed ID: 9776264
[TBL] [Abstract][Full Text] [Related]
14. Safety, hemodynamic profile, and feasibility of dobutamine stress technetium myocardial perfusion single-photon emission CT imaging for evaluation of coronary artery disease in the elderly.
Elhendy A; van Domburg RT; Bax JJ; Valkema R; Reijs AE; Krenning EP; Roelandt JR
Chest; 2000 Mar; 117(3):649-56. PubMed ID: 10712987
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of dobutamine-atropine stress (99m)Tc-tetrofosmin myocardial perfusion SPECT in patients with known or suspected coronary artery disease.
Schinkel AF; Elhendy A; van Domburg RT; Bax JJ; Roelandt JR; Poldermans D
J Nucl Med; 2002 Jun; 43(6):767-72. PubMed ID: 12050321
[TBL] [Abstract][Full Text] [Related]
16. Dobutamine technetium-99m tetrofosmin SPECT imaging for the diagnosis of coronary artery disease in patients with limited exercise capacity.
Elhendy A; Sozzi FB; Valkema R; van Domburg RT; Bax JJ; Roelandt JR
J Nucl Cardiol; 2000; 7(6):649-54. PubMed ID: 11144480
[TBL] [Abstract][Full Text] [Related]
17. Dobutamine stress myocardial perfusion imaging in coronary artery disease.
Elhendy A; Bax JJ; Poldermans D
J Nucl Med; 2002 Dec; 43(12):1634-46. PubMed ID: 12468513
[TBL] [Abstract][Full Text] [Related]
18. Dobutamine stress myocardial perfusion imaging.
Geleijnse ML; Elhendy A; Fioretti PM; Roelandt JR
J Am Coll Cardiol; 2000 Dec; 36(7):2017-27. PubMed ID: 11127435
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
